Ainos, Inc. Files 8-K with Corporate Updates
Ticker: AIMDW · Form: 8-K · Filed: Jun 20, 2024 · CIK: 1014763
| Field | Detail |
|---|---|
| Company | Ainos, INC. (AIMDW) |
| Form Type | 8-K |
| Filed Date | Jun 20, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-update, filing, financials
Related Tickers: AIMD
TL;DR
Ainos (AIMD) filed an 8-K on June 20th covering corporate changes and financials as of June 14th.
AI Summary
Ainos, Inc. filed an 8-K on June 20, 2024, reporting events as of June 14, 2024. The filing includes amendments to its articles of incorporation or bylaws, a Regulation FD disclosure, and financial statements and exhibits. The company, formerly Amarillo Biosciences Inc., is incorporated in Texas and its fiscal year ends on December 31.
Why It Matters
This 8-K filing provides crucial updates on Ainos, Inc.'s corporate structure and financial reporting, which are important for investors to understand the company's current status and regulatory compliance.
Risk Assessment
Risk Level: low — The filing is a routine 8-K reporting corporate updates and financial statements, not indicating any immediate financial distress or significant new risks.
Key Players & Entities
- Ainos, Inc. (company) — Registrant
- Amarillo Biosciences Inc. (company) — Former company name
- June 14, 2024 (date) — Earliest event reported date
- June 20, 2024 (date) — Filing date
- Texas (jurisdiction) — State of incorporation
FAQ
What specific amendments were made to Ainos, Inc.'s articles of incorporation or bylaws?
The filing indicates that amendments were made, but the specific details of these amendments are not provided in the provided text excerpt.
What is the primary business of Ainos, Inc. according to its SIC code?
Ainos, Inc. is classified under SIC code 2834, which corresponds to Pharmaceutical Preparations.
When did Ainos, Inc. change its name from Amarillo Biosciences Inc.?
The date of the name change from Amarillo Biosciences Inc. to Ainos, Inc. was May 16, 1996.
What is the fiscal year end for Ainos, Inc.?
The fiscal year end for Ainos, Inc. is December 31.
What are the key items reported in this Form 8-K filing?
This Form 8-K reports Amendments to Articles of Incorporation or Bylaws, Regulation FD Disclosure, and Financial Statements and Exhibits.
Filing Stats: 811 words · 3 min read · ~3 pages · Grade level 11.4 · Accepted 2024-06-20 16:15:15
Key Financial Figures
- $0.01 — ch registered Common Stock, par value $0.01 per share AIMD The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 45KB
- ex3-1.htm (EX-3.1) — 77KB
- ex99-1.htm (EX-99.1) — 23KB
- 0001493152-24-024514.txt ( ) — 383KB
- aimd-20240614.xsd (EX-101.SCH) — 4KB
- aimd-20240614_def.xml (EX-101.DEF) — 26KB
- aimd-20240614_lab.xml (EX-101.LAB) — 36KB
- aimd-20240614_pre.xml (EX-101.PRE) — 25KB
- form8-k_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Ainos, Inc. Date: June 20, 2024 By: /s/ Chun-Hsien Tsai Name: Chun-Hsien Tsai Title: Chief Executive Officer